TGF-β is associated with increased Treg cells, IFN-g, decreased NK cytotoxicity, immune-suppressive tumor microenvironment, and increased tumor angiogenesis, due, in part, to the stable expression of PD-L1 and VEGF, as well as the induction of the EMT. The gene discussed is TGFB1; the disease is neoplasm.